Cdk5 rescued hippocampal synaptic plasticity in a mouse model of Fragile X Syndrome, a genetic form of intellectual disability associated with epilepsy, autism, and mood disorders, suggesting that activation of Cdk5 activity might be a pharmacological tool to treat Fragile X Syndrome [113]. The gene discussed is CDK5; the disease is Intellectual disability.